Skip to main content

Want a detailed portfolio tracker?

OS Therapies (OSTX) P/E (2024 - 2026)

OS Therapies (OSTX) P/E from Aug 1, 2024 to Jul 21, 2026. The TTM OS Therapies (OSTX) P/E is -1.58. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of OS Therapies (OSTX)

YearP/EChange
2026-1.58+2.06%
2025-1.55-76.07%
2024-6.47N/A

Comparison OS Therapies (OSTX) P/E with competitors

OS Therapies (OSTX) P/E is -1.58.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.11%
NBYStablecoin Development Corp0.00-100.27%
ENLVEnlivex Ltd0.07-104.73%
FGENFibroGen Inc0.24-115.19%
CHRSCoherus Biosciences Inc0.85-153.70%
FBIOFortress Biotech Inc0.95-160.06%
AGENAgenus Inc3.01-290.46%
INVAInnoviva Inc3.15-299.60%
VXRTVaxart Inc3.55-324.65%
CRMDCorMedix Inc3.63-329.63%
CVACCureVac N.V.4.45-381.35%
GLPGGalapagos NV4.86-407.50%
SRPTSarepta Therapeutics Inc4.88-408.96%
ABEOAbeona Therapeutics Inc5.39-440.95%
ABUSArbutus Biopharma Corp5.60-454.12%
ZVRAZevra Therapeutics Inc5.89-472.58%
SPROSpero Therapeutics Inc6.23-494.17%
CGENCompugen Ltd6.31-499.58%
RIGLRigel Pharmaceuticals6.87-534.90%
SLXNSilexion Therapeutics Corp7.30-561.73%
OMEROmeros Corporation9.26-685.94%
AUPHAurinia Pharmaceuticals Inc9.58-706.59%
PLXProtalix BioTherapeutics Inc10.89-789.24%
ACADAcadia Pharmaceuticals Inc11.73-842.25%
TBPHTheravance Biopharma Inc12.26-876.02%
ADMAAdma Biologics Inc12.42-885.89%
HRMYHarmony Biosciences Holdings Inc13.82-974.62%
SABSSAB Biotherapeutics Inc14.14-994.62%
NAGENiagen Bioscience Inc14.82-1037.77%
INCYIncyte Corp15.82-1101.34%
REGNRegeneron Pharmaceuticals Inc15.86-1103.50%
PBYIPuma Biotechnology Inc17.32-1195.83%
CPRXCatalyst Pharmaceuticals Inc17.44-1203.66%
EXELExelixis Inc17.54-1209.90%
TGTXTG Therapeutics Inc18.97-1300.28%
MDXGMimedx Group Inc20.55-1400.68%
XOMAXOMA Royalty Corp22.87-1547.68%
ARGXArgen X SE24.30-1637.75%
CTMXCytomX Therapeutics Inc24.82-1670.86%
XOMAOXOMA Royalty Corp25.34-1704.00%
HALOHalozyme Therapeutics Inc25.62-1721.65%
XOMAPXOMA Royalty Corp25.67-1724.59%
VRTXVertex Pharmaceuticals Inc27.99-1871.71%
RPRXRoyalty Pharma plc - Class A28.69-1915.56%
SLNOSoleno Therapeutics Inc29.02-1936.30%
ASNDAscendis Pharma A/S30.09-2004.03%
LGNDLigand Pharmaceuticals Inc - Class B37.91-2499.35%
APLSApellis Pharmaceuticals Inc39.02-2569.55%
BMRNBiomarin Pharmaceutical Inc42.21-2771.47%
KRYSKrystal Biotech Inc45.34-2969.66%
ONCBeiGene Ltd69.54-4501.02%
PHARPharming Group N.V.75.03-4848.16%
TECHBio-Techne Corp101.96-6552.67%
VCELVericel Corp109.92-7056.62%
ALNYAlnylam Pharmaceuticals Inc117.96-7565.69%
GMABGenmab140.29-8978.62%
TLXTelix Pharmaceuticals Ltd162.15-10362.21%
CORTCorcept Therapeutics Inc212.86-13571.17%